Clinical utility of hereditary cancer panel testing: Impact of PALB2 , ATM , CHEK2 , NBN , BRIP1 , RAD51C , and RAD51D results on patient management and adherence to provider recommendations

Title
Clinical utility of hereditary cancer panel testing: Impact of PALB2 , ATM , CHEK2 , NBN , BRIP1 , RAD51C , and RAD51D results on patient management and adherence to provider recommendations
Authors
Keywords
-
Journal
CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-11-04
DOI
10.1002/cncr.32572

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now